New buprenorphine treatment option approved for opioid use disorder

被引:0
|
作者
不详
机构
来源
NURSE PRACTITIONER | 2023年 / 48卷 / 08期
关键词
D O I
暂无
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
引用
收藏
页码:48 / 48
页数:1
相关论文
共 50 条
  • [1] Monthly Buprenorphine Injection Approved for Opioid Use Disorder
    Voelker, Rebecca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (03): : 220 - 220
  • [2] Buprenorphine Treatment for Opioid Use Disorder: An Overview
    Matisyahu Shulman
    Jonathan M. Wai
    Edward V. Nunes
    CNS Drugs, 2019, 33 : 567 - 580
  • [3] Buprenorphine Treatment for Opioid Use Disorder: An Overview
    Shulman, Matisyahu
    Wai, Jonathan M.
    Nunes, Edward V.
    CNS DRUGS, 2019, 33 (06) : 567 - 580
  • [4] Adherence to Buprenorphine Treatment in Opioid Use Disorder
    Williams, Ted D.
    Sumner, Michael
    Dixit, Shailja
    Urbaniak, Dennis
    AMERICAN JOURNAL ON ADDICTIONS, 2022, 31 (04): : 278 - 278
  • [5] Buprenorphine: a potential new treatment option for opioid dependence
    Srivastava, Anita
    Kahan, Meldon
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (13) : 1835 - 1836
  • [7] Buprenorphine treatment for opioid use disorder: recent progress
    Parida, Suprit
    Carroll, Kathleen M.
    Petrakis, Ismene L.
    Sofuoglu, Mehmet
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 791 - 803
  • [8] Optimizing opioid use disorder treatment with naltrexone or buprenorphine
    Rudolph, Kara E.
    Diaz, Ivan
    Luo, Sean X.
    Rotrosen, John
    Nunes, Edward, V
    DRUG AND ALCOHOL DEPENDENCE, 2021, 228
  • [9] Buprenorphine-Naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy
    Perry, Briana N.
    Vais, Simone
    Miller, Melissa
    Saia, Kelley A.
    OBSTETRICS AND GYNECOLOGY, 2020, 135 : 51S - 51S
  • [10] Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy
    Perry, Briana N.
    Vais, Simone
    Boateng, Jeffery O.
    Jain, Mayuri
    Wachman, Elisha M.
    Saia, Kelley A.
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (06) : E389 - E394